Pureos Bioventures - aVenture Asset Manager Research
Pureos Bioventures
Operating Status: Operating
Pureos Bioventures: A Zurich-based venture capital fund investing in innovative biological drug development.
Location
Küsnacht, Zürich, CH
Pureos Bioventures is a Zurich-based venture capital fund focused on investing in private innovative drug development companies. The firm emphasizes investments in the next generation of biological drugs and drug formats, targeting companies developing innovative therapeutics for severe diseases and conditions. Pureos typically participates in Series A funding rounds.
Notable portfolio companies include Mediar Therapeutics, which has raised $85 million. Pureos Bioventures aims to impact patients' lives by advancing innovative treatments for severe diseases. The firm's strategy involves providing venture capital to support the development of cutting-edge therapeutics, demonstrating a commitment to driving innovation in the biotech and pharmaceutical sectors.
Pureos Bioventures - Portfolio Snapshot
Portfolio activity breakdown across disclosed investments and stages